These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1997017)

  • 1. Experience with digoxin immune Fab (ovine) in patients with renal impairment.
    Wenger TL
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):21-3; discussion 33-4. PubMed ID: 1997017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of clinical experience with digoxin immune Fab (ovine).
    Smith TW
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):1-6; discussion 33-4. PubMed ID: 1997014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study.
    Hickey AR; Wenger TL; Carpenter VP; Tilson HH; Hlatky MA; Furberg CD; Kirkpatrick CH; Strauss HC; Smith TW
    J Am Coll Cardiol; 1991 Mar; 17(3):590-8. PubMed ID: 1993775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of multicenter studies of digoxin-specific antibody fragments in managing digitalis intoxication in the pediatric population.
    Woolf AD; Wenger TL; Smith TW; Lovejoy FH
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):16-20; discussion 33-4. PubMed ID: 1997016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of digitalis intoxication with emphasis on the clinical use of digoxin immune Fab.
    Allen NM; Dunham GD
    DICP; 1990 Oct; 24(10):991-8. PubMed ID: 2244414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic histories and reactions of patients treated with digoxin immune Fab (ovine) antibody. The Digibind Study Advisory Panel.
    Kirkpatrick CH
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):7-10; discussion 33-4. PubMed ID: 1997020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.
    Antman EM; Wenger TL; Butler VP; Haber E; Smith TW
    Circulation; 1990 Jun; 81(6):1744-52. PubMed ID: 2188752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of digitalis effects by specific antibodies.
    Larbig D; Raff U; Haasis R
    Pharmacology; 1979; 18(1):1-8. PubMed ID: 368816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of the use of digoxin immune Fab (ovine) for treatment of digoxin toxicity.
    Mauskopf JA; Wenger TL
    Am J Cardiol; 1991 Dec; 68(17):1709-14. PubMed ID: 1746476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fab fragments of antidigoxin antibodies and acute digitalis poisoning].
    Tribouilloy C; Vovan A; Isorni C; Castier B; Lesbre JP
    Ann Cardiol Angeiol (Paris); 1986 Oct; 35(8):469-73. PubMed ID: 3813453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digibind: emergency treatment for digitalis toxicity.
    Riddle K; Lee AJ
    J Emerg Nurs; 1989; 15(3):266-8. PubMed ID: 2657175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning.
    Lapostolle F; Borron SW; Verdier C; Taboulet P; Guerrier G; Adnet F; Clemessy JL; Bismuth C; Baud FJ
    Crit Care Med; 2008 Nov; 36(11):3014-8. PubMed ID: 18824911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
    Ujhelyi MR; Robert S
    Clin Pharmacokinet; 1995 Jun; 28(6):483-93. PubMed ID: 7656506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digitalis intoxication and treatment with digoxin antibody fragments in renal failure.
    Erdmann E; Mair W; Knedel M; Schaumann W
    Klin Wochenschr; 1989 Jan; 67(1):16-9. PubMed ID: 2921838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of a patient with severe digitoxin intoxication by Fab fragments of anti-digitalis antibodies.
    Kurowski V; Iven H; Djonlagic H
    Intensive Care Med; 1992; 18(7):439-42. PubMed ID: 1469187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.
    Smith TW; Butler VP; Haber E; Fozzard H; Marcus FI; Bremner WF; Schulman IC; Phillips A
    N Engl J Med; 1982 Nov; 307(22):1357-62. PubMed ID: 6752715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of digitalis intoxicated patients following the administration of digoxin FAB antibodies (Digibind).
    Ujhelyi M
    Conn Med; 1990 Feb; 54(2):63-4. PubMed ID: 2306942
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutralization of free digoxin-like immunoreactive components of oriental medicines Dan Shen and Lu-Shen-Wan by the Fab fragment of antidigoxin antibody (Digibind).
    Dasgupta A; Szelei-Stevens KA
    Am J Clin Pathol; 2004 Feb; 121(2):276-81. PubMed ID: 14983943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.